Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 18Neoplasms 18Breast Neoplasms 16Colorectal Neoplasms 12Carcinoma, Non-Small-Cell Lung 11Lung Neoplasms 10Urinary Bladder Neoplasms 6Squamous Cell Carcinoma of Head and Neck 6Hematopoietic and Lymphatic System Neoplasm 6Hematologic Neoplasms 6Ovarian Neoplasms 5Neoplasm Metastasis 5Triple Negative Breast Neoplasms 4Leukemia, Myeloid, Acute 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Pancreatic Neoplasms 3Multiple Myeloma 3Mouth Neoplasms 3Hematopoietic and Lymphoid System Neoplasm 3Head and Neck Neoplasms 3Fallopian Tube Neoplasms 3Carcinoma, Renal Cell 3Sarcoma 2Radiodermatitis 2Peritoneal Neoplasms 2Pathologic Complete Response 2Parotid Neoplasms 2Motor Activity 2Melanoma 2Malignant Solid Neoplasm 2

Interventions

Standard of Care 1Specimen Handling 1Respiratory Physiological Phenomena 1Practice Guidelines as Topic 1Platinum 1Nivolumab 1Magnetic Resonance Spectroscopy 1Etoposide 1Drug Therapy 1Cisplatin 1Carboplatin 1Bleomycin 1Biopsy 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Endodermal Sinus Tumor × Standard of Care × Clear all
NCT03067181 2026-05-05

Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors

Children's Oncology Group

Phase 3 Recruiting
1,780 enrolled

Neoplasms, Germ Cell and Embryonal, Teratoma, Carcinoma, Embryonal, Endodermal Sinus Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡